key: cord-1012365-7lhoq10e
authors: Van Damme, Wim; Dahake, Ritwik; van de Pas, Remco; Vanham, Guido; Assefa, Yibeltal
title: COVID-19: Does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics?
date: 2020-11-25
journal: Med Hypotheses
DOI: 10.1016/j.mehy.2020.110431
sha: e7b11f030fb55c88b4041f854cc498049722f69b
doc_id: 1012365
cord_uid: 7lhoq10e

The variation in the speed and intensity of SARS-CoV-2 transmission and severity of the resulting COVID-19 disease are still imperfectly understood. We postulate a dose-response relationship in COVID-19, and that “the dose of virus in the initial inoculum” is an important missing link in understanding several incompletely explained observations in COVID-19 as a factor in transmission dynamics and severity of disease. We hypothesize that: (1) Viral dose in inoculum is related to severity of disease, (2) Severity of disease is related to transmission potential, and (3) In certain contexts, chains of severe cases can build up to severe local outbreaks, and large-scale intensive epidemics. Considerable evidence from other infectious diseases substantiates this hypothesis and recent evidence from COVID-19 points in the same direction. We suggest research avenues to validate the hypothesis. If proven, our hypothesis could strengthen the scientific basis for deciding priority containment measures in various contexts in particular the importance of avoiding super-spreading events and the benefits of mass masking.

The collective image of what constitutes "the COVID-19 epidemic" has been shaped worldwide by the highly mediatized dramatic outbreaks in countries such as China, Italy, Spain, the United Kingdom (UK), the United States (US), and Brazil. However, the significant variation in the speed and intensity of SARS-CoV-2 transmission, and the severity of the resulting COVID-19 are still imperfectly understood. There are still many incompletely explained observations and uncertainties that are crucial in understanding transmission and anticipating the relative impact of containment measures. 1 We think that the importance of the dose of the virus in the inoculum is being neglected and that it is likely that a dose-response relationship (infection intensity) is an important missing link in understanding COVID-19, both as a factor in the severity of disease and transmission dynamics. 4 

We postulate a dose-response relationship in COVID-19: the "dose of virus in initial inoculum" relates to the severity of disease and intensity of transmission. In our opinion, it is plausible that: 1. At an individual level: "viral dose in inoculum is related to severity of disease (doseresponse relationship)". 2. At a cluster level: "severity of disease is related to transmission potential", leading to clusters of mild cases and clusters of severe cases. 3 . At a community level: "in certain contexts, chains of severe cases can build up through intensive transmission with high inoculum to severe local outbreaks, which can result in large-scale intensive epidemics; while this is less likely in other contexts".

This theory plays out in practice on these three levels: a) Individual level: A person infected with a small dose viral inoculum will on average develop milder disease than a person infected with a high viral inoculum and vice versa. This is independent of other well-known risk factors for severity of disease, mainly old age, and co-morbidities, such as diabetes. b) Cluster level: A person with asymptomatic infection or mild disease, will on average spread lower dose of the virus, and is less likely to transmit disease; and when the person transmits, the newly infected person is more likely to have mild disease compared to a person infected by a severely ill person, who spreads on average higher doses of virus. This causes clusters and chains of milder cases or more severe cases. c) Community level: In certain contexts, such as dense urban centres with a moderate climate, during the season that people live mostly indoors, the potential for intensive 5 transmission and explosive outbreaks is higher than in rural areas, or in regions with a hot and humid climate where people live mostly outdoors. Hence, a cascade of intensive transmission is more likely in certain contexts than in others. 6 

A minimum quantity of infectious particles required to establish infection ("minimum infectious dose") varies across different pathogens; whether this infection subsequently causes disease, and the severity of the disease will depend both on the infectious agent and the host's immune response. Over decades of research, many studies have also consistently shown the importance of the dose of the pathogen in the inoculum in many infectious diseases ( 

In COVID-19, a potential dose-response relationship is especially difficult to prove, as it may be dwarfed by the very strong correlation between severity of the disease and advanced age and co-morbidities.

Despite that difficulty, emerging evidence consistent with a dose-response relationship between the infecting dose and disease severity has been recently observed in three clusters of individuals that were exposed to diverse inocula and developed divergent clinical forms of COVID-19 disease. 27 The potential infecting doses were determined by the extent of physical distancing and precautionary measures that the individuals followed. It was evident that in the clusters which did not follow physical distancing or other precautions, such as wearing masks, a larger proportion of individuals developed severe disease, whereas only asymptomatic or mild disease was seen in the cluster, where exposure had been low. 27 The severity of the disease following transmission from pre-symptomatic/mild cases has been documented. Some studies have shown that transmission from a pre-symptomatic person (who later developed a mild disease) resulted in mild diseases in the secondary cases, which is concordant with our hypothesis. 28 It has also been documented that transmission from children, with mild disease, also resulted in mild disease in secondary cases. [29] [30] [31] Immunological evidence: Immune responses to SARS-CoV-2-implications of the role of the dose of the initial inoculum on viral clearance

The expression of COVID-19 in an individual is related to the exposure to SARS-CoV-2 and the competency of one's immune system. Effective immune responses against viral infections largely depend on the early innate responses and the downstream cascade that eventually help 8 to control viral replication and induces adaptive immune responses. However, several viruses including SARS-CoV-2 have developed mechanisms to inhibit or evade these initial innate responses. Knowledge on immune response to SARS-CoV-2 is summarised in Table 2 and key differences between immune responses in mild and severe COVID-19 in Table 3 .

We postulate that the dose of the initial viral inoculum can partly explain the differences in the immune responses elicited in mild and severe COVID-19 ( Figure 1) . A low dose of SARS-CoV-2 initial inoculum is likely to trigger a cascade of immune responses that leads to downstream viral clearance. It is also more likely that a smaller dose of viral inoculum will stimulate a protective immune response and hence result in milder disease, while a higher dose of the viral inoculum will evade the immune response and/or create chaos in the immune system leading to more severe disease. 37 38 Higher doses evade this initial response and trigger a delayed response of secondary lines of defence (such as IFN-I) over broader areas of tissues and often trigger inflammation, which leads to severe disease. 38 It is plausible that low doses of SARS-CoV-2 activate the innate immunity component of the immune system which responds with moderate levels of protective cytokines and IFN pathway activation. Additionally, the virus further activates the adaptive immunity component and causes early apoptosis of viral-infected cells by CTLs and NK cells and robust anti-viral neutralizing antibody responses, which eventually lead to mild or indolent disease. In contrast, high doses of SARS-CoV-2 initial inoculum block or delay the activation of the IFN pathway and cause an elevated pro-inflammatory cytokine response which may lead to cytokine storms. The high dose of the initial inoculum also may lead to high dose 9 induced immune suppression, causing downstream apoptosis of CTLs and NK cells leading to lymphocytopaenia, inefficient T and B cell responses (due to "functional exhaustion"), and impaired neutralizing antibody responses all leading to severe COVID-19.

Interestingly, asymptomatic patients appear to have weaker immune responses to SARS-CoV-2 infection. 39 In persons who are asymptomatic or have mild disease, exposure to SARS-CoV-2 induces cellular immune (T cell) responses even without sero-conversion (SARS-CoV-2 specific antibodies), especially in familial contact with infected individuals. 40, 41 Index cases for most of these secondary cases resulting in mild or asymptomatic disease also experience mild/moderate COVID-19. 40 These robust memory T cell responses even without the presence of antibodies may be protective against further or recurrent SARS-CoV-2 infections.

In our opinion, these observations could be correlated to lower doses of exposure to SARS-CoV-2 and strengthen the importance of the dose of the initial viral inoculum in downstream immune responses.

Super-spreading events have been documented all over the world, typically in crowds or confined spaces. Transmission is especially plausible while infected persons are singing or talking loudly, particularly in poorly ventilated spaces. 43, 44 An online database (https://bit.ly/3ar39ky) created by the London School of Hygiene & Tropical Medicine (LSHTM) lists several such events. 45 It is estimated that 1-20% of infected individuals (super-spreaders) result in 80% of secondary cases. 46-49 10 There is anecdotal evidence that health workers with low-risk profile developed severe COVID-19 when infected during high exposure contacts such as intubation of a COVID-19 patient leading to intensive coughing. 5, [50] [51] [52] COVID-19 has spread especially fast and explosively in colder climates such as North Italy, France, Belgium, and New York and less explosively or later in hot and humid climates.

Colder climates with mostly indoor events in closed environments create a more conducive context for exposure to a high dose of virus, than hotter climate where people live mostly outdoors, and where aerosols diffuse more rapidly. 53 However, air-conditioning systems, especially those that re-circulate air, may create indoor environments with high potential for dense contamination and transmission. Evidence on the high likelihood of airborne transmission of SARS-CoV-2 is accumulating. 54, 55 Although asymptomatic transmission of SARS-CoV-2 has been well documented, an asymptomatic person might well have a lower potential for spreading the virus in the absence of coughing and sneezing. Table 4 Such studies could include re-analysis of super-spreading events, from an epidemiological gaze keeping the hypothesis in mind. An analysis of one such super-spreading event in Germany has yielded insights, entirely consistent with our hypothesis. 65 

The infectious dose is related to the amount of virus expelled through respiratory droplets/aerosols while an infected individual is coughing/sneezing, but also possibly when talking, laughing, singing etc. An important element for such research is that viral loads in respiratory droplets and aerosols need to be studied, as this is more likely to correlate with the potential dose of the virus in the initial infectious inoculum. This is very difficult, and therefore most current literature focuses on the amount of the virus in nasopharyngeal swabs as an indicator in viral transmission dynamics; however, we think it is a poor substitute.

Virological studies, that measure viral load in expelled respiratory droplets/aerosols as a determinant for transmission should be undertaken. Viral culture of the respiratory droplets/aerosols could be done to determine infectious dose which can then be correlated The potential for high-probability high-dose (or high-intensity) transmission is undoubtedly greatest during close contact with an infected person with respiratory symptoms, frequently spreading infected droplets and aerosols, such as during coughing and sneezing. Close encounters with symptomatic COVID-19 patients typically occur in health care settings, in nursing homes, or during home-care for a sick person. Particularly high-risk are medical 16 procedures touching respiratory mucosae, such as during aspiration of respiratory secretions, sampling for PCR tests, and especially during intubation, potentially triggering coughing or sneezing. There is no doubt that strict barrier and hygiene measures in such situations remains a top priority, especially for older health care workers and care givers.

The potential for transmission with a high-dose inoculum is probably also high during prolonged exposure to air containing aerosols and droplets with high viral loads, such as in poorly ventilated crowded spaces, where an infected person is speaking loudly or singing, even if the infected person is asymptomatic. Colder temperatures in such an environment could prolong the viability of the virus in aerosols. One infected person in such crowded places can easily cause intensive transmission in several people. It is thus likely that not only more transmission can occur in these settings, but also that such high-dose transmission will potentially result in more severe disease. This is especially relevant when high-risk persons attend such crowded events (e.g. funerals, religious services, choirs, etc.).

Evidence on the inoculum hypothesis could thus further strengthen the evidence base for the generally recognised priority interventions in health care settings and elderly homes. It would also strengthen the rationale for focusing on gatherings in spaces with environments conducive to super-spreading events, in which the role of ventilation and air-conditioning may have been neglected till now. Too often, avoidance of potential super-spreading events is lumped together in a measure, such as, "gatherings of more than 20 or 50 or 100 people are forbidden," while the risks are totally different for an open-air gathering (such as walking, playing, or running in public spaces) attended by young people with enough space for physical distancing, as compared to a social gathering with elderly people in a crowded indoor space. 17 Our hypothesis would also strengthen the rationale for mass masking, including welldesigned and well-fitting multi-layered home-made masks in public spaces, especially when interacting in poorly ventilated places with other people at a close distance. [74] [75] [76] Mass masking remains controversial in many countries; not only for cultural reasons but also since some experts continue to question their effectiveness. However, it likely decreases both the frequency of transmission and the infectious inoculum if a transmission still occurs. It has indeed been shown that viral loads in respiratory droplets being emitted while talking or breathing out are significantly less when masks are used. 77 It has also been postulated that mass masking not only limits the transmission of the infection, but also protects the wearer from severe disease, by reducing the inoculum that may potentially lead to infection. 78 While masks that are currently being prescribed for the general public (such as home-made cloth masks or commercially available surgical masks) do not completely prevent infection as compared to more specialized FFP2/N95 masks, wearing any type of mask could potentially reduce intensity of exposure and lead to a milder disease. 76 It is thus very plausible that mass masking leads to chains of individuals with asymptomatic or mild disease. Although such chains of asymptomatic or mild disease may seem beneficial in generating community-level immunity, 79 whether that is actually possible remains to be elucidated, especially with recent reports of several individuals getting re-infected. 80 Nonetheless, such chains of asymptomatic or mild disease will undoubtadely reduce the burden on the healthcare system. 18 

In our opinion, the role of the dose of the initial inoculum in the transmission dynamics of SARS-CoV-2 has been neglected. Based on evidence from other infectious diseases and observations from the current SARS-CoV-2 transmission dynamics, immune responses against SARS-CoV-2, and the COVID-19 disease spectrum, we think that the dose-response relationship in the initial viral inoculum plays an important role in the severity of the COVID-19 epidemic. While immunological responses in mild versus severe COVID-19 disease provide valuable information in understanding the role of the dose of the initial inoculum, certain intrinsic immunity components such as the role of mucosae in preventing infection are still a grey area. In addition, it is very evident that a different efficacy of both innate and immune responses, according to age and co-morbid conditions is a confounding factor. This is especially in the younger and older part of the population: the former may better resist to a higher dose, the latter may be more susceptible to a lower dose. All this considerably complicates establishing insights in a dose-response relationship, and has to be carefully separated out in any research.

We propose that additional research will potentially generate insights relevant for prioritising strategies to decrease the impact of the epidemic.

More attention should be given when assessing risk whether activities are outdoors or indoors, and to the ventilation of the space. This is often neglected by medical experts, who most often have a focus on transmission between individuals, and may give less consideration to the importance of the context and the space in which transmission occurs, than engineers and architects, who also include air circulation and ventilation in their analyses. 19 This calls for greater involvement of experts on built environments in transmission research.

They also should get a stronger voice, along with social scientists, in advising policies and analysing the risks in events and other situations.

Insights on the importance of transmission dynamics, such as while caring for a sick person, or in environments conducive to super-spreading events should also be communicated to the general public, so that "dangerous settings" are more widely identified and avoided or palliated. It may be more important to understand the space, the air circulation and the mix of individuals attending a gathering than the number of people in attendance. There should be greater public awareness that, for instance, a gathering in a poorly-ventilated, noisy, closed, and crowded environment with elderly people speaking loudly is conducive for high-intensity transmission, and that one infected person coughing, singing, or shouting could create a perfect storm, infecting several high-risk individuals with a high inoculum, potentially triggering a cascade of further infections and triggering a local hotspot, with severe COVID-19 cases.

In conclusion, our hypothesis could contribute to more selective, feasible and sustainable containment strategies to reduce the severity of the COVID-19 epidemic, with a lower or more acceptable societal and economic cost. It specifically would further strengthen the rationale for the importance of avoiding super-spreading events in crowded indoor environments, and for the benefits of mass masking. 20 

No specific funding was provided for this study. depends significantly on the infectious dose. 13 33  High volume of the viral inoculum leads to shorter incubation periods and faster disease progression. 14  The relation between viral load in the blood (cut-off 1500 copies/mL) and the chances of heterosexual transmission has been repeatedly and convincingly shown in studies with discordant couples. 15, 16 Measles  Higher initial doses associated with more severe disease and higher mortality in secondary (multiple) cases that arise from index cases within the house environment than single cases that arise from an index case outside the house, 17 

The COVID-19 pandemic: diverse contexts; different epidemics-how and why?

A Dosefinding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans

A dynamical model of human immune response to influenza A virus infection

Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic

Systematic review of influenza

A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age. Influenza and other respiratory viruses

Viral shedding and clinical illness in naturally acquired influenza virus infections. The Journal of infectious diseases

Viral load distribution in SARS outbreak

Initial viral load and the outcomes of SARS

Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia. Emerging infectious diseases

Effects of a "new" human respiratory virus in volunteers

UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure

Natural history of HIV-1 infection

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

Probability of HIV-1 transmission per coital act in monogamous

HIV-1-discordant couples in Rakai

Assumptions and contradictions in measles and measles immunization research: is measles good for something?

Severe measles: a reappraisal of the role of nutrition, overcrowding and virus dose

Epidemiology of tuberculosis in the United States

Quantity and Quality of Inhaled Dose Predicts Immunopathology in Tuberculosis

Ultra-low dose of Mycobacterium tuberculosis aerosol creates partial infection in mice

Outbreak of tuberculosis among regular patrons of a neighborhood bar

Extensive transmission of Mycobacterium tuberculosis from a child. The New England journal of medicine

Relationship between the inoculum dose of Streptococcus pneumoniae and pneumonia onset in a rabbit model

Do superspreaders generate new superspreaders? A hypothesis to explain the propagation pattern of COVID-19

Viral Dose and Immunosuppression Modulate the Progression of Acute BVDV-1 Infection in Calves: Evidence of Long Term Persistence after Intra-Nasal Infection

Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. The New England journal of medicine

SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal transduction and targeted therapy

Immunology of COVID-19: Current State of the Science

Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients

The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?

Coronavirus infections

Epidemiological, clinical and immunological features and hypotheses. Cell Stress

Innate Immune Evasion by Human Respiratory RNA Viruses

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without Seroconversion

Robust T cell immunity in convalescent individuals with asymptomatic or mild

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? Aerosol science and technology : the journal of the American Association for Aerosol Research

Presymptomatic Transmission of SARS-CoV-2 -Singapore

What settings have been linked to SARS-CoV-2 transmission clusters?

Why do some COVID-19 patients infect many others, whereas most don't spread the virus at all? Science

Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel

Centre for the Mathematical Modelling of Infectious Diseases

Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China

Clustering and superspreading potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Hong Kong

illness in healthcare workers: Too many unknowns

Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China. The Journal of hospital infection

Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review

virus by droplets and aerosols: A critical review on the unresolved dichotomy

Airborne route and bad use of ventilation systems as non-negligible factors in SARS-CoV-2 transmission

COVID-19 Outbreak Associated with Air Conditioning in Restaurant

Probability of symptoms and critical disease after SARSCoV-2 infection

SARS-CoV-2 Infection in Children. The New England journal of medicine

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. The Lancet Infectious diseases

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

The role of children in the transmission of mild SARS-CoV-2 infection

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Characteristics of COVID-19 infection in Beijing

Air Quality Expert Group -Department for Environment Food & Rural Affairs

Report: Estimation of changes in air pollution emissions, concentrations and exposure during the COVID-19 outbreak in the UK. 2020

Infection fatality rate of SARS-CoV-2 infection in a German community with a superspreading event

The Role of Super-Spreaders in Infectious Disease

Initial infectious dose dictates the innate, adaptive, and memory responses to influenza in the respiratory tract

Risk analysis : an official publication of the Society for Risk Analysis

Dose-response and transmission: the nexus between reservoir hosts, environment and recipient hosts

Dose-response assessment for influenza A virus based on data sets of infection with its live attenuated reassortants

Dose-response models for selected respiratory infectious agents: Bordetella pertussis, group a Streptococcus, rhinovirus and respiratory syncytial virus

Deducing the Dose-response Relation for Coronaviruses from COVID-19, SARS and MERS Meta-analysis Results

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

World Health Organization. Advice on the use of masks in the context of COVID-19

Professional and home-made face masks reduce exposure to respiratory infections among the general population

Respiratory virus shedding in exhaled breath and efficacy of face masks

Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer

Facial Masking for Covid-19 -Potential for "Variolation" as We Await a Vaccine. The New England journal of medicine

None declared. 21